Anpario (LON:ANP – Get Free Report) had its price target hoisted by equities research analysts at Canaccord Genuity Group from GBX 550 to GBX 570 in a research note issued on Thursday, Marketbeat reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 3.64% from the stock’s previous close.
Separately, Shore Capital restated a “house stock” rating on shares of Anpario in a report on Monday, January 19th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Anpario presently has a consensus rating of “Buy” and a consensus price target of GBX 570.
Get Our Latest Report on Anpario
Anpario Stock Up 3.8%
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
- Five stocks we like better than Anpario
- Buy This Stock at 9:30 AM on MONDAY!
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.
